ArticleCell death & disease2025

A novel clinically relevant antagonistic interplay between prolactin and oncogenic YAP-CCN2 pathways as a differentiation therapeutic target in breast cancer.

Xueqing Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.